Literature DB >> 28572385

Structural basis for antibody-mediated neutralization of Lassa virus.

Kathryn M Hastie1, Michelle A Zandonatti1, Lara M Kleinfelter2, Megan L Heinrich3, Megan M Rowland3, Kartik Chandran2, Luis M Branco3, James E Robinson4, Robert F Garry3,5, Erica Ollmann Saphire6,7.   

Abstract

The arenavirus Lassa causes severe hemorrhagic fever and a significant disease burden in West Africa every year. The glycoprotein, GPC, is the sole antigen expressed on the viral surface and the critical target for antibody-mediated neutralization. Here we present the crystal structure of the trimeric, prefusion ectodomain of Lassa GP bound to a neutralizing antibody from a human survivor at 3.2-angstrom resolution. The antibody extensively anchors two monomers together at the base of the trimer, and biochemical analysis suggests that it neutralizes by inhibiting conformational changes required for entry. This work illuminates pH-driven conformational changes in both receptor-binding and fusion subunits of Lassa virus, illustrates the unique assembly of the arenavirus glycoprotein spike, and provides a much-needed template for vaccine design against these threats to global health.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28572385      PMCID: PMC6007842          DOI: 10.1126/science.aam7260

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  50 in total

1.  Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-C.

Authors:  Marc Froeschke; Michael Basler; Marcus Groettrup; Bernhard Dobberstein
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

2.  X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation.

Authors:  Sébastien Igonet; Marie-Christine Vaney; Clemens Vonrhein; Clemens Vonhrein; Gérard Bricogne; Enrico A Stura; Hans Hengartner; Bruno Eschli; Félix A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

3.  Molecular Mechanism for LAMP1 Recognition by Lassa Virus.

Authors:  Hadas Cohen-Dvashi; Nadav Cohen; Hadar Israeli; Ron Diskin
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.

Authors:  Hadas Cohen-Dvashi; Hadar Israeli; Orly Shani; Aliza Katz; Ron Diskin
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

5.  Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.

Authors:  Stefan Kunz; Jillian M Rojek; Motoi Kanagawa; Christina F Spiropoulou; Rita Barresi; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.

Authors:  Sabrina Schrempf; Marc Froeschke; Tsanan Giroglou; Dorothee von Laer; Bernhard Dobberstein
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Unusual molecular architecture of the machupo virus attachment glycoprotein.

Authors:  Thomas A Bowden; Max Crispin; Stephen C Graham; David J Harvey; Jonathan M Grimes; E Yvonne Jones; David I Stuart
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.

Authors:  Anders Krarup; Daphné Truan; Polina Furmanova-Hollenstein; Lies Bogaert; Pascale Bouchier; Ilona J M Bisschop; Myra N Widjojoatmodjo; Roland Zahn; Hanneke Schuitemaker; Jason S McLellan; Johannes P M Langedijk
Journal:  Nat Commun       Date:  2015-09-03       Impact factor: 14.919

9.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany.

Authors:  Svenja Wolff; Tilman Schultze; Sarah Katharina Fehling; Jan Philipp Mengel; Gerrit Kann; Timo Wolf; Markus Eickmann; Stephan Becker; Torsten Hain; Thomas Strecker
Journal:  Genome Announc       Date:  2016-09-22
View more
  88 in total

1.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Authors:  Helena Müller; Sarah Katharina Fehling; Jens Dorna; Richard A Urbanowicz; Lisa Oestereich; Yvonne Krebs; Larissa Kolesnikova; Martin Schauflinger; Verena Krähling; N'Faly Magassouba; Elisabeth Fichet-Calvet; Jonathan K Ball; Andreas Kaufmann; Stefan Bauer; Stephan Becker; Veronika von Messling; Thomas Strecker
Journal:  NPJ Vaccines       Date:  2020-08-04       Impact factor: 7.344

3.  Analysis of Oligomeric and Glycosylated Proteins by Size-Exclusion Chromatography Coupled with Multiangle Light Scattering.

Authors:  Kathryn Hastie; Vamseedhar Rayaprolu; Erica Ollmann Saphire
Journal:  Methods Mol Biol       Date:  2021

4.  Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.

Authors:  Antra Zeltina; Thomas A Bowden
Journal:  Nat Struct Mol Biol       Date:  2017-07-06       Impact factor: 15.369

5.  Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).

Authors:  Hinh Ly; Yuying Liang; Junjie Shao; Qinfeng Huang; Xiaoying Liu; Da Di; Mythili Dileepan; Morgan Brisse
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

6.  Movement Patterns of Small Rodents in Lassa Fever-Endemic Villages in Guinea.

Authors:  Joachim Mariën; Fodé Kourouma; N'Faly Magassouba; Herwig Leirs; Elisabeth Fichet-Calvet
Journal:  Ecohealth       Date:  2018-03-23       Impact factor: 3.184

7.  Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.

Authors:  Chiara Fedeli; Giulia Torriani; Clara Galan-Navarro; Marie-Laurence Moraz; Hector Moreno; Gisa Gerold; Stefan Kunz
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

8.  Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.

Authors:  Takao Hashiguchi; Yoshinari Fukuda; Rei Matsuoka; Daisuke Kuroda; Marie Kubota; Yuta Shirogane; Shumpei Watanabe; Kouhei Tsumoto; Daisuke Kohda; Richard Karl Plemper; Yusuke Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

9.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

10.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.